Journal of Cancer Immunology & Therapy

About The Journal Open Access

Journal of Cancer Immunology & Therapy

The journal welcomes submissions from all related fields to the Cancer Immunology & Therapy which utilises the immune system as a treatment for cancer. Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well-known application is cancer immunotherapy.

Aims and Scope

Journal of Cancer Immunology & Therapy is a peer-reviewed, open access journal that reflects articles on all types of tumor immunology. The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.

Journal of Cancer Immunology & Therapy organize a new platform for the researchers, scientists, scholars, students in this field to publish their research work & update the latest research information to the scientific community. Chief criteria for acceptance are scientific novelty and quality, originality, clarity, and conciseness with early online publication, regular podcasts and an immense archive collection.

You may submit manuscripts online at http://www.editorialmanager.com/alliedjournals/default.aspx or you may send the article as an email attachment to the e-mail id [email protected] / [email protected]

Please submit your manuscript to
[email protected]

Just Published Articles View More

Review Article February 10, 2018

P.25-39

J Cancer Immunol Ther: 1(1): 25-39

Modelling approaches in tumor microenvironment.

Isaac Crespo, George Coukos, Marie-Agnes Doucey and Ioannis Xenarios

Review Article December 18, 2017

P.16-22

J Cancer Immunol Ther: 1(1): 16-22

Advanced and metastatic soft tissue sarcoma, a review of aajcc 8th edition staging and the use of olaratumab.

Hari A Deshpande, Ranjan Pathak, Fauzia Riaz

Review Paper December 14, 2017

P.8-15

J Cancer Immunol Ther: 1(1): 8-15

Recent advances in exosome-based cancer immunotherapy.

Yubin Zhou, Qun Zeng, Herbert Schwarz

Short Communication December 14, 2017

P.6-7

J Cancer Immunol Ther: 1(1): 6-7

MRI-guided stereotactic radiation therapy for prostate cancer: a mini review.

Aryavarta M S Kuma

Editorial October 25, 2017

P.4-5

J Cancer Immunol Ther: 1(1): 4-5

Impact of immune checkpoint inhibitors in cancer immunotherapy.

Kota V Ramana

Editorial October 25, 2017

P.3-3

J Cancer Immunol Ther: 1(1): 3-3

High-dose chemotherapy in germ cell tumors: an old story still young.

Giovanni Rosti